Tech Update: Business leaders go on a shopping spree in Q2
According to recent insights from global market analysts LSEG Data and Analytics, the second quarter of 2025 saw close to US$82 billion in activity in Canada.
Interestingly, while the total value of takeovers in Q2 2025 was 84 per cent higher than the same period last year, fewer deals were made: LSEG counted just 593 deals compared to 825 deals in Q2 2024.
These numbers may be heartening for those concerned about keeping Canadian companies in Canada. At Toronto Tech Week, a panel of leaders from Shopify, Cohere and Wealthsimple emphasized the power of rejecting foreign acquisitions and focusing on domestic deals for more sustainable company growth.
Indeed, one of the best ways for Canadian companies to grow is to buy another.
Toronto-based software company Security Compass recently added Devici, a North Carolina startup specializing in AI threat modelling, to its portfolio as part of its strategic growth plan.
As CEO Rohit Sethi explains, one of his company's key offerings, SD Elements, is like a blueprint that shows software developers which security requirements they need to integrate.
But, Sethi notes, there was a gap in that platform's capabilities. Security Compass wanted to provide a service that would help clients understand different ways attackers might break into their systems.
While it's possible to build in-house, Sethi says it can be more effective — and far more efficient — to acquire a pre-existing program that's already trusted by customers.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CTV News
a few seconds ago
- CTV News
S&P/TSX composite down in late-morning trading, U.S. stock markets also lower
TORONTO — Losses in industrial and telecommunication stocks weighed on the Toronto market as Canada's main stock index fell in late-morning trading, while U.S. stock markets also pulled back. The S&P/TSX composite index was down 78.55 points at 27,308.38. In New York, the Dow Jones industrial average was down 149.30 points at 44,335.19. The S&P 500 index was down 3.89 points at 6,293.47, while the Nasdaq composite was down 15.60 points at 20,870.05. The Canadian dollar traded for 72.89 cents US compared with 72.71 cents US on Thursday. The September crude oil contract was up 78 cents US at US$67.01 per barrel. The August gold contract was up US$14.80 at US$3,360.10 an ounce. --- This report by The Canadian Press was first published July 18, 2025.
Cision Canada
a few seconds ago
- Cision Canada
Quarterhill Files Final Base Shelf Prospectus
TORONTO, July 18, 2025 /CNW/ - Quarterhill Inc. ("Quarterhill" or the "Company") (TSX: QTRH) (OTCQX: QTRHF), announces today that it has obtained a receipt for its final short form base shelf prospectus with the securities commissions in each of the provinces and territories of Canada, except Quebec. As previously announced, the final base shelf prospectus allows the Company to qualify the distribution by way of prospectus in Canada of up to C$200 million of common shares, preferred shares, debt securities, warrants, subscription receipts, units, or any combination thereof, during the 25-month period that the base shelf prospectus is effective. The specific terms of any offering under the base shelf prospectus will be established in a prospectus supplement, which will be filed with the applicable Canadian securities regulatory authorities in connection with any such offering. The shelf prospectus will enable the Company to access new capital or issue securities in connection with strategic acquisitions, if and when needed. The amount and timing of any future offerings or issuances will be based on the Company's financial requirements and market conditions at that time. A copy of the final short form base shelf prospectus can be found on SEDAR+ at This press release does not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any jurisdiction in which an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. About Quarterhill Quarterhill is a leading provider of tolling, safety and enforcement, and logistics solutions in the Intelligent Transportation System (ITS) industry. Our goal is technology-driven global leadership in ITS, via organic growth of our businesses, and by continuing an acquisition-oriented investment strategy that capitalizes on attractive growth opportunities within ITS and its adjacent markets. Quarterhill is listed on the TSX under the symbol QTRH and on the OTCQX Best Market under the symbol QTRHF. For more information: Forward-looking Information This news release contains forward-looking information and forward-looking statements within the meaning of applicable Canadian securities laws (collectively, "forward-looking statements"). Such forward-looking statements relate to future events, conditions or future financial performance of Quarterhill based on future economic conditions and courses of action. All statements other than statements of historical fact may be forward-looking statements. Such forward-looking statements are often, but not always, identified by the use of any words such as "seek", "anticipate", "budget", "plan", "goal", "expect" and similar expressions. Specifically, this news release contains forward-looking statements relating to, but not limited to: the filing and effectiveness of any potential prospectus supplement in the future; future financing opportunities; the amount and terms of any securities to be offered under one or more shelf prospectus supplement(s); and the Company's focus on its acquisition strategy. Forward-looking statements involve known and unknown risks, assumptions, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. Material risk factors that could cause actual results to differ materially from the forward-looking statements contained in this news release include, among others, demand for Quarterhill's products and services; general economic and market conditions; competition; risks relating to technological advances and cyber-security; force majeure risks; and other risks set forth in the Company's most recent annual information form available on SEDAR+ at The Company believes the expectations reflected in the forward-looking statements are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward-looking statements included in this news release should not be unduly relied upon. Material factors and assumptions used to develop the forward-looking statements contained in this news release include, among others: Quarterhill's ability to execute on its business plan; demand for Quarterhill's products and services; operating assumptions; and financial projections and cost estimates. These foregoing lists are not exhaustive. Additional information on these and other factors which could affect the Company's operations or financial results are included in the Company's most recent annual information form and other public documents on file with the Canadian Securities regulatory authorities on The forward-looking statements represent the Company's views as at the date of this news release. There can be no assurance that forward-looking statements will prove to be accurate, as actual events and future events could differ materially from those anticipated in such statements. Readers should not place undue reliance on any forward-looking statement. The Company does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by applicable securities law.
National Post
30 minutes ago
- National Post
Ostia Sciences Inc. Completes $1.46M Seed Round to Develop Microbiome Therapeutics Platform.
Article content The company receives additional non-dilutive funding from Natural Products Canada. Article content TORONTO — Ostia Sciences Inc., a microbiome therapeutics company developing next-generation probiotics, today announced the successful close of its seed financing round, raising CAD $1.46 million as of December 31, 2024. Article content Article content In addition to private investment, Ostia secured over $393,000 in non-dilutive grants, including $350,000 from Natural Products Canada (NPC) through its Proof-of-Concept (POC) program. Article content The NPC POC funding will help advance Ostia's planned clinical trials, focusing on natural solutions for widespread conditions like gingivitis, halitosis, and treatment-related oral complications of head and neck cancer patients. Article content 'Our progress reflects both strong investor confidence and essential support from Canadian innovation programs, enabling the commercialization of natural health solutions and helping millions of patients worldwide,' said Dr. Abdelahhad Barbour, CEO of Ostia Sciences. 'We now have the resources to optimize our manufacturing processes and move SALI-10 toward clinical validation.' Article content With full ownership of its IP portfolio, an expanding team of advisors, and a robust discovery pipeline, Ostia Sciences is positioning itself as a leader in microbiome-based biotherapeutics. Article content 'We're building more than just a product, we're creating a platform for targeted, microbiome-driven drug development,' said Dr. Michael Glogauer, Chief Scientific Officer. 'This funding brings us one step closer to transforming how we treat oral and respiratory diseases.' Article content Article content Article content Article content
